Status:
COMPLETED
Support for COVID19 Patients at Home
Lead Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Collaborating Sponsors:
Istituto Auxologico Italiano
Azienda Ospedaliera Bolognini di Seriate Bergamo
Conditions:
COVID19 Patients
Eligibility:
All Genders
18+ years
Brief Summary
The rapid spread and increase of acute respiratory infection cases caused by the novel SARS-CoV-2 coronavirus represent a major challenge for healthcare systems around the world. The shortage of facil...
Detailed Description
The MIRATO Project wants to test the remote health surveillance services and a telemonitoring program for patients discharged after a period of hospitalization for COVID19 caused by the new coronaviru...
Eligibility Criteria
Inclusion
- Hospitalisation for COVID19
- Patients discharged at home
Exclusion
- Patient refusal
- Patients discharged at a nursing home
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 16 2022
Estimated Enrollment :
796 Patients enrolled
Trial Details
Trial ID
NCT04898179
Start Date
November 1 2020
End Date
January 16 2022
Last Update
October 15 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Socio Sanitaria Territoriale (ASST) BERGAMO EST, Ospedale Bolognini di Seriate
Seriate, Bergamo, Italy
2
Ics Maugeri
Lumezzane, Brescia, Italy, 25065
3
Ics Maugeri
Tradate, Varese, Italy
4
Istituto Auxologico Italiano
Milan, Italy